# Monitoring Mutational Burden in Low Risk MDS Patients Using Sequential Peripheral Blood Samples

> **NCT04251078** · — · RECRUITING · sponsor: **Josep Carreras Leukaemia Research Institute** · enrollment: 200 (estimated)

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04251078
- **Lead sponsor:** Josep Carreras Leukaemia Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-01-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04251078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04251078, "Monitoring Mutational Burden in Low Risk MDS Patients Using Sequential Peripheral Blood Samples". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04251078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*